Profit Or Loss [Abstract]

Sopharma Trading AD - Filing #6022483

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Raw materials and consumables used	—	—	10 703 BGN	—	—	—	—	—	—	—	—	10 536 BGN	—	—
Employee benefits expense	—	—	92 804 BGN	—	—	—	—	—	—	—	—	83 095 BGN	—	—
Depreciation and amortisation expense	—	—	32 071 BGN	—	—	—	—	—	—	—	—	29 984 BGN	—	—
Other expenses, by nature	—	—	5 345 BGN	—	—	—	—	—	—	—	—	5 141 BGN	—	—
Profit (loss) from operating activities	—	—	45 012 BGN	—	—	—	—	—	—	—	—	40 341 BGN	—	—
Finance income	—	—	518,000 BGN	—	—	—	—	—	—	—	—	755,000 BGN	—	—
Finance costs	—	—	11 319 BGN	—	—	—	—	—	—	—	—	7 092 BGN	—	—
Profit (loss) before tax	—	—	34 211 BGN	—	—	—	—	—	—	—	—	12 393 BGN	—	—
Tax expense (income)	—	—	5 003 BGN	—	—	—	—	—	—	—	—	3 313 BGN	—	—
Profit (loss)	- BGN	- BGN	29 208 BGN	29 208 BGN	- BGN	- BGN	- BGN	- BGN	- BGN	- BGN	- BGN	9 080 BGN	9 080 BGN	- BGN
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	0.8500	—	—	—	—	—	—	—	—	0.2600	—	—